ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BDX Common Shares

0.75
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Common Shares CSE:BDX CSE Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.75 0.51 0.73 0 01:00:00

VIDEO from Medialink and BD Diagnostics: New Technology Now Available to Monitor AIDS Patients in Africa

01/12/2006 2:01pm

PR Newswire (US)


Common Shares (CSE:BDX)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Common Shares Charts.
NEW YORK, Dec. 1 /PRNewswire/ -- According to the latest UNAIDS/WHO report, nearly 40 million worldwide are now living with HIV/AIDS. This year alone, 2.9 million people have died and another 4.3 million are newly infected. While sub-Saharan Africa has just more than 10 percent of the world's population, it is home to more than 60 percent of all people infected -- with more than 24 million people now living with HIV/AIDS. (See video at: http://media.medialink.com/WebNR.aspx?story=32773) New technologies now exist to address some of the unique challenges faced by the fragile healthcare systems of sub-Saharan Africa, challenges not faced here in the United States. For the first time, a specially designed blood collection tube -- called the BD Vacutainer(R) CD4 Stabilization Blood Collection Tube -- is now available throughout Africa. Designed for the unique circumstances of extreme heat and long distances samples endure, this new technology will help monitor and manage HIV positive patients. CD4 cell counting tells physicians how strong an HIV positive person's immune system is and helps them determine a course of treatment. With standard blood collection tubes, the integrity of the samples will break down within a few hours -- and by the time they reach the testing facility, as many as 20 percent need to be discarded. Experts predict the new device will improve accuracy and reduce costs associated with CD4 testing. Registered journalists can access video, audio, text, graphics and photos for free and unrestricted use at http://media.medialink.com/. DATASOURCE: Medialink and BD Diagnostics CONTACT: Medialink New York, +1-888-560-5578 or Web site: http://media.medialink.com/

Copyright

1 Year Common Shares Chart

1 Year Common Shares Chart

1 Month Common Shares Chart

1 Month Common Shares Chart

Your Recent History

Delayed Upgrade Clock